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FAMILIAL PRIMARY SYSTEMIC AMYLOIDOSIS: AN
EXPERIMENTAL, GENETIC AND CLINICAL STUDY*
JOHN C. RUKAVINA, M.D., WALTER D. BLOCK, Pri.I). AND A. C. CURTIS, M.D.
Familial primary systemic amyloidosis, a relatively unrecognized facet of the
amyloid problem, represents an unusual disease process with protean manifesta-
tions. Genetic, clinical and pathological data with reference to this entity has
beea confirmed in four case reports in the world literature (1—4).
Maxwell and Kimball (1), on the basis of autopsy findings in three middle
aged brothers, submitted the first report alluding to the familial aspect of sys-
temic amyloidosis. The clinical data in these cases was not remarkable nor were
the genetic implications discussed by these workers. Ostertag (2) in 1950 re-
ported autopsy-proven amyloidosis on two brothers ages 35 and 39. There was
suggestive clinical evidence that the mother of these patients and a daughter of
them were afflicted with a similar process.
Andrade (3) in 1952 described a bizarre disease occurring endemically in the
Oporto Region of Portugal. Locally it was known as "Mal dos peinhos" (foot
disease). This insidious and relentless affliction was characterized by an essen-
tially universal neurologic involvement. Paresis, particularly of the lower ex-
tremities, was a common finding. There was early impairment of thermal and
pain sensitivities predominantly in the lower extremities. Gastroenteric disorders
(flatulence, constipation, diarrhea) represented a distressing complication. Sexual
disturbances in the male were the earliest and most constant complaints in the
cases studied. The disease began in the second and third decades with an appar-
ent predilection for males. In a number of cases gradual deterioration and death
occurred in seven to ten years. Fifty-one of sixty-four cases reported were
familial: ten families were genetically independent, two families were related,
while thirteen cases were isolated and unrelated. While a large part of this ma-
terial represents clinical and laboratory data, autopsies of two cases revealed
definite histopathologic evidence of primary systemic amyloidosis.
Kantarj ian and DeJong (4) added further genetic, clinical and pathological
data to this entity. A father and two daughters were studied with positive
necropsy findings in the father and one of the daughters. The syndrome de-
scribed was not unlike that of Andrade (3) and consisted of neurologic signs and
symptoms compatible with a severe progressive peripheral ncuropathy, gastro-
intestinal symptomatology, and cardiovascular involvement. These workers
further expanded the clinical spectrum in that they found endocrine abnormali-
ties consisting of thyroid enlargement, low basal metabolic rate, amenorrhea,
and impotence in the male. Remarkable ocular findings consisting of retinal
exudates and exophthalmos were also described. On the basis of their genetic
data they assumed the inheritance pattern to be a simple dominant.
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An unusual opportunity for the study of this inherited process presented
itself when two cousins H. D. (case 16) and A. D. (case 11) were referred to our
hospital in 1953 for the study of an unusual syndrome consisting essentially of
neurologic and ophthalmologic symptomatology. Historical data secured from
these patients suggested a reservoir of clinically similar cases in a genetically
isolated community. Dne to the remarkable degree of patient cooperation to-
gether with unstinted aid from physicians at the local level, sixty-six members
of this pedigree agreed to submit to an intensive investigation of this inherited
pathological process.
Case Report I. the propositus of this pedigree, H. I). (ease 16), age 50 years, was ad-
mitted to the hospital April 16, 1953. His chief complaints were those of poor eyesight,
generalized weakness and fatigue, mild recurrent chest pain on exertion, and numbness of
the hands and legs.
The patient was uncertain as to the duration of his symptoms. Trauma to the left eye
seemed to precipitate the onset of his visual difficulty even though recovery seemed to
ensue after treatment. Two years prior to admission he noted the onset of "floating" spots
in his left eye accentuated by prolonged eye strain. A similar process involved the right
eye a year later. Apparently the onset of fatigue and weakness was insidious as he noted
"tiredness" upon climbing stairs and while doing his farm work. Recurrent mild chest
pain on effort coupled with slight breathlessness was of relatively recent origin. Continuous
numbness and pain in the hands and feet represented the most troublesome complaint.
According to the patient the hand discomfort was present for a "long time" while that of
the lower extremities represented a new development of approximately two years duration.
A concomitant incoordination further complicated the clinical picture. Nocturnal hand
pain, unrelieved by any medication, resulted in the inability to sleep. The patient further
volunteered the information that the "hand difficulty" had also troubled his father and
his paternal uncle.
Physical examination: Temperature, pulse, and respiration were normal. Blood pres-
sure was 162/110. No macroglossia was noted. The lungs were clear to auscultation and
percussion. There was suggestive clinical evidence of cardiac enlargement. No murmurs
or unusual heart sounds were heard. Examination of the abdomen gave essentially negative
results. There were no remarkable skin changes.
The important findings on physical examination were those involving the ocular and
neurologic systems. The external examination of the eye was normal as was ocular motility.
The pupils were aniseoric, the left being larger than the right (6.5mm.). Pupillary reflexes
were prompt and equal. There was no abnormality of the anterior segments by slit lamp
examination. Ophthalmoseopic examination revealed a massive degree of dense sheets of
semi-opalescent hyaline-like opacities in the right eye. These opacities were attached in
scattered fashion to the internal limiting membrane of the retina. Patchy bead-like de-
posits were noted on the surfaces of the retinal arterioles. The retinal veins were involved
in a similar process. No other gross retinal pathology could be seen and the disc and macular
area seemed to be uninvolved. The architecture of the left eye was obliterated by a similar
and more severe process resulting in faint visualization of retinal details. A peripheral
branch of the inferior temporal arteriole demonstrated a white bead-like deposit on its
surface. Visual fields were done with only slight peripheral constriction being noted (5).
Neurological examination revealed a male with normal intelligence. There was decreased
pin prick, light touch, and vibration sense bilaterally over the areas of median nerve dis-
tribution. There was peripheral blunting of superficial sensation over the upper and lower
extremities. Deep sensibilities were essentially within normal limits excepting the second
and third fingers on the right and the second finger of the left hand. There was bilateral
thenar atrophy with paresis of the opponens and lateral lumbrical muscles (Fig. 1). The
transverse carpal ligaments were thickened and appeared to be snugly attached to the
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FIG. 1. Bilateral thenar atrophy in a 58 year old patient (ease 1). The earpal tunnel
syndrome was nnt present in this subject.
overlying structures (earpal tunnel syndrome). Deep tendon reflexes were hvpoactive in
the upper and completely absent in the lower extremities. Muscle strength seemed to he
diminished universally.
Laboratory data: routine blood and urinalysis were normal. The urine tests for Bence-
Jones protein were negative. The results of serologic tests were negative. A fasting blood
sugar was normal. X-ray of the chest revealed cardiomegaly without parenchymal pul-
monary disease. X-rays of the skull and colon were normal. Roentgen ray examination of
the hands revealed evidence of hypertrophic arthritis. An electrocardiogram showed an
incomplete left branch block, suggestive of myocardial changes. Spinal fluid examination
was essentially negative. An intravenous congo red test was interpreted as being "positive"
(with no record as to the amount absorbed). Microscopic examination of the gingival
tissue revealed a thickening of the blood vessel walls which was suggestive of amyloid
deposition. Free electrophoresis of the patient's serum revealed an atypical serum protein
peak arbitrarily designated as m' (6).
The patient was discharged from the hospital April IS, 1953. His subsequent course was
that of a slight but definite progression of his ocular, cardiologic and neurologic symptoms.
He expired suddenly October 24, 1954 while resting at home.
An autopsy was done the same day. Significant gross findings were limited to the heart
and lungs. The heart was markedly enlarged, weighing 840 grams. The epicardium was
covered with small verrucous lesions in the region of the right ventricle measuring 5 mm.
in diameter. The coronary vessels were patent and showed no appreciable evidence of
atherosclerosis. Upon opening the chambers of the heart, the endocardial surfaces of the
atria and the valves were somewhat roughened and pebbly having a tan-gray color. The
chorda tendinae were grossly normal. The walls of the heart were markedly thickened; the
left ventricle measuring 2.5 cm. in thickness and that of the right ventricle 1 cm. The cut
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FIG. 2. Microscopic section of myocardium (case 16) (high power, HE. stain) showing
disruption of myofibril and large patchy areas of amyloid infiltration.
surface of this muscle was pale tan to pink in color. The intraventricular septum was simi-
larly involved.
There were also found a bilateral pleural effusion with atelectasis of the lower lung
segments. The liver, spleen, lymph nodes, pancreas, adrenal glands, the gastroenteric
tract, the prostate, kidneys and skin were grossly normal. Unfortunately, no nerve tissue
changes were described nor was any material secured for microscopic study. Eye examina-
tion was not permitted.
Histopathologie examination of the tissue (hematoxylin and eosin, congo red, and crystal
violet stains) revealed extensive amyloid deposits in the myocardium and (Fig. 2, 3) in
the vessels and substance of the tongue (Fig. 4). Marked vessel involvement of the larynx,
liver, spleen, adrenal glands, pancreas, lungs, prostate, and kidneys was described. No
amyloid was found in the bone marrow or skin. The final anatomic diagnosis was primary
systemic amyloidosis with death being due to cardiac failure.
Cese Report II. A. U. (case 11), age 52 years, a cousin of the propositus, (H. 1)., ease 16)
presented with symptoms consisting of numbness and pain in the hands and visual dis-
turbances consisting of "floating specks" in the eyes. Symptoms referrable to the hands
were first noted at 20 years of age and were markedly accentuated at rest and when exposed
to cold. For an indeterminate period of time relief was attained by hard manual labor.
However, currently the symptoms were accentuated both at labor and at rest. Treatment
has been ineffective in alleviating the manual pain.
Symptoms referrable to the ocular system had their onset seven years prior to admission.
There was a continuous progression of "floaters" and "specks" in the eye to the current
disability of not being able to read a newspaper nor drive a car, nor to recognize familiar
rices and figures.
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FIG. 3. Microscopic section of myocardium, case 16, (high power, HE. stain) showing
amyloid "rings" in the fat tissue of the heart.
FIG. 4. Microscopic section of tongue, case 16, (high power, HE. stain) demonstrating
profuse amyloid involvement of a lingual artery (a). A similarly involved artery is located
near the left lower section of the specimen (h).
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Other less troublesome symptoms were those of epigastric distress after a fatty meal and
a definite loss of potentia of long standing. The remainder of the history was essentially
non-contributory.
Physical examination: temperature, pulse, and respiration were normal. The blood
pressure was 130/90. Ocular examination revealed defective visual acuity with ability to
count fingers limited to two feet. Pupil size and reflexes were normal. Slit lamp examina-
tion was essentially negative. Ophthalmoscopic examination revealed massive, obstructing
semi-opalescent, sheath-like hyaline vitreous opacities in the right eye which obscured
the retinal details except for glial proliferation from the retinal surface noted in the ex-
treme periphery. The left retina was normal except for a localized white exudate on the
surface of the inferior nasal arteriole. The visual fields, perimeter, and Bjerrum screen was
normal to 3/300 and 1/1000 white test objects respectively on the left eye. A large central
scotoma was found to 8.7/1000 white test object. Subsequent ophthalmoscepic examination
two years later demonstrated an almost complete hyaline opacification of the vitreous
which markedly limited the examination. However, bead-like deposits were noted on the
superior nasal and temporal inferior nasal arterioles. In the extreme periphery of the retina
the opacities assumed a coral-reef like appearance and seemed to he attached to the retinal
surface. Examination of the nose and throat was negative. There was no evidence of macro-
glossia. The lymph nodes were not enlarged. Auscultation and percussion of the chest was
negative. Examination of the abdomen revealed the presence of an enlarged, non-tender,
non-nodular liver. The genitalia were those of a normal adult male. Rectal examination
revealed no abnormalities. The skin of the hands was indurated, shiny and bound down
resembling scleroderma in a remarkable fashion (Fig. 5). Neurologic examination revealed
Fro. 5. Comparison of the parchment-like erythematous fingers and palm (case 1) of a
58 year old patient (left) with those of normal (right). Note also thenar atrophy.
fr
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a definite reduction in hearing in the left ear. A definite reduction in sensation to touch
(cotton) and pain (pin prick) from the elbows to the finger tips was noted. This diminution
of sensation increased distally. Similar findings wore described below the knees in the lower
extremities. Position sense was normal and there was no fasciculation or atrophy of the
extremities. Hand strength was markedly reduced as was the ability to extend and flex
the hands. Flexion, extension and abduction of the thumb was reduced. Abduction, exten-
sion, external and internal rotation of the shoulders was diminished. Flexion-extension
weakness of the elbows and that of the wrists was prominent. Dorsal flexion of the feet
was diminished otherwise the lower extremities were not remarkable. Peripheral pedal
vessel pulsations were reduced bilaterally.
Laboratory data: routine blood and urinalysis were normal. The urine tests for Bence-
Jones protein wore negative. The results of serologic studies were normal. Blood urea nitro-
gen was 14.0 mgm. per cent. Bleeding time was 2 minutes 30 seconds and coagulation time
10 minutes 7 seconds. Cryoglobulin determinations were negative. Study of the liver func-
tion revealed a direct serum bilirubin of 0.12 mgm. and a total of 0.7 mgm., bromsulfalein
retention 0 per cent, cephalin flocculation 1 plus at 48 hours, thymol turbidity 4.5 units,
zinc turbidity 12.5 units, alkaline phosphatase 1.1 units, prothrombin time patient 15
seconds and control 14 seconds, and a serum cholesterol of 290 mgm. per cent. The electro-
cardiogram showed a moderate left axis deviation with occasional premature contractions.
X-rays of the chest, skull and pelvis were normal. X-ray of the cervical spine revealed
hypcrtrophic arthritic changes at C3 and C6. Pathological examinations of the gingiva and
of the left dorsal index finger were negative with hematoxylin and eosin hut positive for
amyloid deposition with the congo red, crystal violet and periodic acid Schiff stains. Bone
marrow examination was negative for evidence of multiple myeloma. Indirect laryngoscopy
revealed no gross pathology of the vocal cords. Free electrophoresis of the patient's serum
demonstrated an atypical serum protein peak (a2').
PLAN OF INVESTIGATION
Extensive mveStigatioll of this pedigree, utilizing data secured by the family
in this country and in Europe, reveals that the grandparents of H. D. (case 16)
and A. D. (ease 11) emigrated to this country from the Canton Berne, Switzer-
land in 1883. Unlike other emigres from Europe, the members of this family
group came directly to a small community in northeastern Indiana without
intermediate settlement thus maintaining relative genetic isolntion.
The program of investigation of this pedigree encompassed four broad areas:
1. That of careful histories and physical examinations. 2. Comprehensive labo-
ratory procedures consisting of routine blood, urine studies, and further analysis
of the urine for Bence-Jones protein. Blood serology, screening procedures for
hepatic, renal, and hemostatic function, cryoglobulin determination, electro-
cardiography, x-ray of the chest and bones, skin biopsies, and bone marrow
examination completed the laboratory program of investigation. 3. Thorough
study of the genetic aspects of the inheritance of this process utilizing familial,
experimental, and legal data. 4. The application of experimental biochemical
studies consisting of free electrophoresis of the serum and ultracentrifugal
analysis of the serum lipoproteins (7, 8). The discovery of an atypical electro-
phoretic peak (a2') in the two cousins suggested the possibility that perhaps
this procedure (free electrophoresis) might represent a means of identification
of those subjects stigmatized by the pathological process.
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METHODS
Free electrophoresis. 2 ml. of fresh centrifuged serum were diluted with 6 ml.
of the veronal buffer at pH 8.6, ionic strength of 0.1 M. The diluted serum was
dialyzed for 18 hours against 500 ml. of buffer at 0° C. Electrophoresis was carried
out on this dialyzed serum for one hour at 1.5° C. A Perkin-Elmer electrophoresis
apparatus (Model 38) was used throughout this study.
The procedure for quantitation of the protein components involved the usual
steps of the enlargement of the patterns, tracing by hand, and planimetry. The
method is essentially that described by Tiselius and Kabat (10). The total pro-
tein content of the original serum was determined by the Biuret method (ii, 12).
Mobility calculations were carried out according to the method described by
Longsworth (13).
Ultracentrifuçal analysis. Blood specimens were drawn at times when the
influence of dietary factors on lipoprotein levels was minimal. Lipoproteins were
determined on fresh serum by ultracentrifugation at a density of 1.21 according
to Lewis, Green and Page (14) modification of Gofman's technic (15). Cholesterol
was determined by the method of Abell et al. (16).
RESULTS
Of the sixty-six subjects studied, twenty-nine showed an abnormal pattern in
the a2 globulin region. In fifteen cases, the presence of an atypical peak between
a2 and /3 globulin fractions, arbitrarily designated a2 was demonstrated. In
fourteen additional cases, the patterns were characterized by poor resolution in the
a2 area. Thirty-seven cases gave normal electrophoretic patterns. Representative
electrophoretic patterns are presented iii Figures 6, 7.
Fx. 6. Representative electrophoresis diagrams of serum in patients with primary
systemic amyloidosis (A) and of normal serum (B). Aib., serum albumin; ai, alpha-protein;
a, alpha2-globulin; abnormal component; 3, beta-globulin; y, gamma-globulin; I,
stationary anomalous boundary.
BA
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FIG. 7. Actual representative electrophoresis diagrams of serum in familial primary
systemic amyloidosis (left) and of a normal serum (right). Note the atypical peak (a2,)
indicated in the left diagram.
No striking quantitative abnormalities could be demonstrated in these atypical
electrophoretic patterns (Table I). The albumin content tends to be somewhat
low and the total globulin content somewhat elevated. These differences, while
suggestive are not significant. The percentages of a, a2, and fi globulins are
normal in these subjects. Of the fifteen cases showing the atypical peak, eight
had low values for a2 globulin, seven had normal values. In fourteen cases with
unresolved a2 globulin areas normal values were present in twelve cases, two
cases being slightly elevated. Here again the trend is suggestive but not signifi-
cant.
Mobility calculations would seem to indicate that in the unresolved patterns
the atypical peak is associated with the a2 globulin fraction. In four cases the
atypical peak appears to lie between the a2 and fi globulin, in three cases between
the al and a2, and in eight cases the mobilities of both components fell within
the normal a2 range. On the basis of these data the position of the atypical peak
remains in question. When the mobility of the peaks in question is related to
the mobility of albumin, it would seem likely that the atypical peak does lie
between aI and j3 globulins.
An attempt was made to determine whether a part of this atypical peak could
be mucoprotein. Electrophoretic patterns were run on two atypical sera at pH
4.5 (17). No abnormality in mucoprotein could be demonstrated.
Lipoprotein determinations were carried out on thirty-three members of this
pedigree. The lipoproteins of all members studied showed the normal comple-
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TABLE II
Serum lipoprotein values determined by ultracentrifu gal analysis at density 1 .z1 in 33 members
studied for familial primary systemic amyloidosis (8)
Ce segaend SeI1m 40-70 25-40 20-25 1-10 Cho1.
mgm/
100 n1.
1 F, 58 Present 28 24 177 14 282 246 Neuropathy, skin biopsy
2 M, 32 Absent <7 <7 141 19 199 215 Symptoms of peripheral neu-
ropathy
3 M, 3 Absent 9 19 160 21 235 191 Negative4 M, 20 Absent <7 4 106 9 141 130 Negative
5 M, 7 Absent 6 24 152 7 141 129 Negative
6 F, 33 Present 7 7 152 14 177 179 Symptoms of neuropathy
7 M, 5 Present * Negative
8 M, 3 Present t Negative
9 F, 30 Present 7 9 129 14 152 147 Skin changes
10 M, 10 Absent 9 4 177 28 194 198 Negative
11 M, 52 Present 14 71 424 14 188 290 Neuropathy, skin biopsy, eye
changes, hepatomegaly
12 F, 22 Present 14 14 139 24 199 210 Neuropathy, splenomegaly
13 M, 32 Present 118 122 354 28 258 326 Anemia, hepatomegaly
14 M, 9 Present 19 14 235 14 188 151 Negative
15 M, 6 Present 75 19 129 16 141 138 Negative
16 M, 52 Present * Neuropathy, eye changes
cardiomegaly
17 M, 22 Present 14 19 141 7 164 126 Eye changes
18 F, 17 Present — 7 106 16 247 162 Negative
19 F, 24 Present 14 16 152 7 118 168 Negative
20 IF, 47 Present 24 24 97 21 — — Neuropathy, heart failure,
hoarseness, gastro-intesti-
nal
21 M, 21 Present * Negative
22 F, 64 Absent 14 28 398 <14 202 370 Neuropathy, hepatomegaly
23 F, 48 Present 24 55 290 12 133 266 Symptoms of peripheral neu-
ropathy, tissue biopsy
24 F, 40 Absent 10 10 198 35 300 226 Neuropathy
25 F, 7 Absent <7 9 157 12 188 159 Negative
26 M, 12 Present 7 9 223 14 129 168 Negative
27 F, 18 Present 108 24 164 14 118 158 Negative
28 F, 73 Present * Symptoms of peripheral neu-
ropathy
29 M, 46 Present 12 35 280 19 235 226 Symptoms of peripheral nell-
ropathy
30 F, 41 Absent 12 7 177 14 171 203 Negative
31 M, 32 Absent 7 16 188 9 106 178 Negative
32 M, 46 Present 9 52 280 12 100 233 Neuropathy, skill changes
hepatomegaly
33 F, 17 Present <7 7 152 19 141 181 Negative
34 M, 16 Present 4 7 118 7 118 165 Negative
35 F, 13 Present 26 14 152 7 101 184 Negative
36 F, 12 Present *
-
Negative
_____________
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TABLE TI—Continued
Case
No.
Sex and
Age
Atypical
Serum
Patterns
-S >
70 40—70 25—40 20—25 1W
Serum
Chol
esterol
Remarks (Signs, Symptoms,
Laboratory data, Etc.)
mgnt/
100 sal
37 M, 44 Absent 56 80 424 14 141 240 Hepatomegaly, gastro-intesti-
nal
38 M, 69 Present 64 35 218 16 141 221 Neuropathy, cardiac insuffi-
ciency
39 M, 39 Present Neuropathy
40 M, 73 Present 4 16 141 7 106 242 Neuropathy, cardiac insuffi-
ciency
* Lipoprotein determination not done.
t Material insufficient for analysis.
ments of components present in normal sera (-S > 70, 40—70, 25—40, 20—25, and
1—10) (Table II).
The average normal human serum lipoprotein values used as a standard were
those of Lewis and Page (18). No normal determinations were available in the
literature for the 1—17 year age range. Several cases reported in the present paper
fell into this group. Those age groups for which normal lipoprotein values are
available (18—34 and 35—60 years) indicate that these values increase with age.
On the basis of this fact it might be speculated that normal values for the 1—17
age group would actually be somewhat lower than those for the 18—34 age group
(19).
Lipoprotein concentrations were found to be within normal limits in six cases
(4, 5, 19, 31, 34, 40). In three of these cases (4, 5, 31) all other data obtained
were normal and the subjects were considered free of systemic amyloidosis. In
the three remaining cases (19, 34, 40) with normal lipoprotein values, electro-
phoretic abnormalities were demonstrated.
Twenty-seven of the thirty-three subj ects revealed abnormal lipoprotein
values. Of this number fifteen were female, twelve were males. Ages ranged from
3—73 years; the females ranging from 3—73, the males from 6—73 years. The mean
age for the females was 33 years, for the males 32 years. Fifteen of the twenty-
seven cases were below 33 years of age.
Analysis of the data showed abnormalities in all components of the sera studied
(Table II). The -S > 70 fraction had the least number of elevations (cases 13,
15, 27). The-S 40—70 component was elevated in four males (cases 11, 13, 32, 37).
Only two females showed significant elevations in this fraction (cases 23, 27).
A rather consistent pattern of abnormality existed in the -S 25—40, 20—25, and
1—10 fractions. In the 25—40 component, abnormal values were found in eight
males (cases 11, 13, 14, 26, 29, 32, 37, 38) and in seven females (cases 3, 22, 23,
25, 27, 33, 35). These elevations were very marked in two males, ages 6 and
12 years.
The -S 20—25 level was elevated in nine males (cases 2, 10, 11, 13, 14, 15, 26,
29, 38) and in ten females (cases 3, 6, 9, 12, 18, 20, 24, 27, 30, 33). Two of the
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affected males were 6 and 12 years of age. Seven of the ten females were under
35 years of age, the youngest being a 3 year old child.
Appreciable increases in the measurable concentrations of the -S 1—10 fraction
were noted in seven males (cases 2, 10, 11, 13, 14, 17, 29) and in five females
(cases 1, 3, 12, 18, 24). The youngest male in this group was 9 years of age, the
youngest female 3 years of age. The serum cholesterol levels were elevated in
only five cases (1, 11, 13, 22, 23).
Correlation of Signs and Symptoms, Genetic Patterns and Experimental Data
In order to render the genetic profile more meaningful the pedigree* has been
divided into cohesive branches labelled A (Fig. 8), B (Fig. 9), C (Fig. 10), D
(Fig. 11). Branch A consisting of 14 cases (1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14,
15) (Fig. 8), and branch D composed of 7 cases (10, 32, 33, 34, 35, 36, 37) (Fig.
11) respectively have been selected for discussion.
Correlation of clinical signs and symptoms of familial systemic amyloidosis
with the electrophoretic findings were remarkable (Tables I and II). Of the fif-
teen subjects with the atypical electrophoretic peak, ten showed clinical signs
and/or symptoms of the disease (cases 6, 11, 12, 13, 16, 17, 20, 23, 28, 40). Of
the fourteen subjects whose electrophoretic patterns were unresolved in the a2
globulin region, six had clinical signs or symptoms of the disease (cases 1, 9,
29, 32, 38, 39). There were thirteen subjects showing atypical electrophoretic
patterns with no apparent manifestations of the disease. It should be noted that
twelve of these thirteen cases were less than twenty-one years of age (cases 7,8,
* The complete genetic profile of kindred 3499 is on file at the University of Michigan He-
redity Clinic.
Q FEMALE. NOT EXAMINED.
MALE. NOT EXAMINED.
PROBABLY AFFECTED.
rI EXAMINED. NORMAL.
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FIG. 9. Branch B, Kindred 3499
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FIG. 10. Branch C, Kindred 3499
14, 15, 18, 21, 26, 27, 33, 34, 35, 36). Of this number seven were thirteen years
of age or less.
The clinical data were next related to the results secured by ultracentrifuga-
tion. In sixteen cases an abnormal concentration of one or more -S fractions was
accompanied by signs and/or symptoms of the disease. There was no sex pre-
ponderance noted in this correlation. Significantly, eleven apparently normal
members, as determined by clinical study, demonstrated a definite increase in
this class of molecules. Of this latter group nine were under 18 years of age.
The data secured by ultracentrifugation were then correlated with that oh-
FEMALE, NOT EXAMINED
MALE, NOT EXAMINED
PROBABLY AFFECTED
11111111 EXAMINED NORMAL
IIIUIIJIJ ELECTROPHORESIS, LIPOPOTEINS
POSITIVE CLINICAL
SIGNS SYMPTOMS
ABNORMAL
ELECTROPHORESIS
ELEVATED
LIPO PROTEINS
PRO POSIT US
FEMALE, NOT EXAMINED
MALE, NOT EXAMINED
PROBABLY AFFECTED
flfl EXAMINED. NORMAL
LLW aEcmoPnoRss LIPOPROTEINS
j POSITIVE CLINICALSIGNS/SYMPTOMS
I ABNORMALELECTRO PH 0 R ES IS
ELEVATED
LI P0 P ROT EIN S
PROPOSITUS
26 27 25
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FIG. 11. Branch D, Kindred 3499
tamed by free electrophoresis. In twelve cases wherein demonstrable quantita-
tive evidence of an a2' peak was found, ten cases (6, 11, 12, 13, 14, 15, 17, 18,
20, 23) (Table II) showed abnormal lipoprotein levels in the -S 25—40 and 20—25
fractions. In those cases wherein the a2electrophoretic peak was poorly resolved,
an increase in the measurable concentrations of the -S 25—40 and 20—25 was
found in nine cases (1, 9, 26, 27, 29, 32, 33, 35, 38) (Table II). In eight cases
with normal electrophoretic patterns, lipoprotein components were found to be
elevated.
Interesting correlations were found between lipoprotein abnormalities and the
inheritance pattern. The data indicate varying degrees of genetic lipoprotein
inheritance. The offspring of case 11 (Fig. 8), consisting of a daughter (case 12),
son (case 13) and two grandsons (cases 14, 15) showed the most marked abnor-
malities in lipoprotein values. One member of this group (case 13), a male age
32 years, showed remarkable elevation in all of the lipoprotein fractions (Table
II). His sons, ages 6 and 9 years respectively, likewise demonstrated unusual
changes in the -S components.
The offspring of case 1 (Fig. 8), embracing a son (case 2), two daughters (cases
6, 9), four grandsons (cases 4, 5, 7, 8), and a granddaughter (case 3), revealed
appreciable concentrations in the -S 20—25 and 1—10 fractions (Table II). Two
members of this group (cases 4, 5) were entirely free of the disease by all meth-
ods of investigation. The most significantly affected member of this unit was a
three year old child (case 3).
The offspring of case 32 (Fig. 11) which demonstrated abnormal lipoprotein
levels in essentially the -S 25—40 fraction consisted of three daughters (cases 33,
35, 36) and a son (case 10) (Table II). A brother (case 37) showed similar changes.
There was no significant pattern of serum cholesterol elevation in any of the
family segments studied.
(J FEMALE. NOT EXAMINED.
MALE. NOT EXAMINED. ooaoto-IPROBABLY AFFECTED.
ELECTROPHORESIS, LIPOPROTEINS IiITI EXAMINED. NORMAL. 37
POSITIVE CLINICAL SIGNS
AND SYMPTOMS.
ABNORMAL LI I IIiELECTROPHORESIS
36 0
I ELEVATEDLIPOPROTEINS.
PROPOSITUS.
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DISCUSSION
Approximately one half of the sixty-six members of a large family pedigree
have been shown by clinical, laboratory and experimental methods to be afflicted
with clinical or sub-clinical primary systemic amyloidosis. In one case (number
16) of this membership, clinical suspicion was confirmed at autopsy. In three
cases, (number 1, 11, 23), a positive tissue biopsy (skin and ovarian tissue) for
amyloid deposition re-enforced the presumptive diagnosis of the disease process
in question.
Evidence secured by this study points to a dominant form of inheritance.
More significantly it emphasizes the importance of the electrophoretic serum and
lipoprotein relationship to the pathological process. Data secured by these
technics substantiate the clinical correctness of the dominant form of trans-
mission (9).
The clinical signs and symptoms of familial amyloidosis described in this
study confirms the observations of previous investigators. In this pedigree, at
least, the broad clinical spectrum represents a predictable, concatenated series of
events culminating in order of descending frequency in peripheral neuropathy,
skin changes, hepatic enlargement and dysfunction, cardiovascular insufficiency,
eye changes, gastrointestinal symptomatology, and splenomegaly. The occur-
rence of the carpal tunnel syndrome represents a previously unreported finding
in the inherited form of the disease. In no case was there clinical evidence of
macroglossia, bleeding tendency, or papulo-nodular dermatologic expression of
the disease.
The extensive laboratory studies, which formed an important aspect of this
investigation, served to effectively rule out co-existing or other disease processes
(multiple myeloma). The experiences of previous workers as to the essentially
noncontributory nature of common laboratory data has been confirmed. Non-
specific findings have consisted of x-ray proven cardiomegaly, various electro-
cardiographic abnormalities, and isolated hematologic abnormalities. The
exhibition of the intravenous congo red test (case 16) presented only suggestive
evidence of the amyloid process. This finding likewise substantiates the experi-
ences of others. While it is still true that the pathological examination of tissue
remains the single most important and generally accessible diagnostic aid, the
caprice with which amyloid responds to the various staining procedures limits
the usefulness of this approach.
The significance of the biochemical experimental approach to the study of
inherited amyloidosis has been alluded to previously. This assumes even greater
significance in that the investigative procedures available to the clinician today
in the study of amyloid deposition do not permit clear-cut and final diagnostic
clarification. The consistent demonstration in these patients with clinical or sub-
clinical disease of an atypical a2' peak by serum free electrophoresis may well
represent a new technical aid for the clinician and the geneticist to study this
disease. Evidence to date also suggests that its application in the diagnosis of
the so-called isolated variety of primary systemic amyloidosis is justified. The
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electrophoretic pattern in the latter form is consonant with those described in
this study.
While the importance of electrophoretically and clinically positive individuals
is not to be overlooked the detection of the subclinical case represents the great-
est justification for the application of this technic. Just as in gout and familial
hypercholesterolemia the clear and effective detection of the subclinical person
vitalizes and validates the genetic statistical data. In this study thirteen cases
were found in which clinical signs and symptoms were lacking, yet free electro-
phoresis revealed either a clearly delineated cr2' peak or poor resolution in the
area between the 2 and 3 globulins. When age in these individuals was correlated
with the serum abnormalities an important finding was seen to emerge: twelve
of these thirteen cases were under 21 years of age.
Several genetic and clinical possibilities suggest themselves as to this relation-
ship. On the one hand, it might emphasize the importance of a time factor: that
is, as these patients approach the second and especially third and fourth decades
of life, the development of clinical amyloidosis represents a distinct possibility.
Two cases to date (cases 12, 17), both in their early twenties, have progressed
into the early phases of the "clinical crossover" (Table II). That this sequence
of events may transpire seems most likely. On the other hand, due to the myriad
inconstant relative capacities of inheritance in man, this serum abnormality may
represent the only life long evidence of this process (carrier state). The carrier
state might also indicate the individual with the appropriate genotype who does
not develop the characteristic clinical findings until late adolescence, middle, or
even old age. Or the carrier might be that person who has inherited a gene which
produces in different persons different expressions of the disease which as yet,
due to the limitations of physical findings and laboratory procedures, remains
undetected. This observation assumes validity especially in primary systemic
amyloidosis since an individual may show no pathological evidence of tissue
involvement due to the vagary of amyloid staining, and yet at necropsy demon-
strate ample evidence of the process. Further, the alleged carrier may be that
individual who has inherited a gene which because of its extreme rarity presents
and is known only in the heterozygous state.
The position of the atypical electrophoretic peak manifested by these patients
suggests even further material for speculation. On the basis of mobility deter-
minations this peak clearly seems to lie between the a2 and 3 globulin fractions.
When all atypical patterns are considered, the situation is by no means so well
defined. Inspection of the unresolved patterns, however, and consideration of
mobilities relative to albumin, support the original finding that peak resides in
the area described.
Four possibilities concerning the nature of the atypical peak have been con-
sidered. The components might conceivably be a mucoprotein or a lipoprotein.
It might arise from a split in the a2 globulin fraction, or it might represent a
protein of unknown, heterogeneous composition. These possibilities are, of course,
not mutually exclusive. For example, the atypical component might be hetero-
geneous and might at the same time arise from the split in the a2 component.
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Part of the heterogeneous fraction could conceivably be mucoprotein, lipoprotein
or both.
Attempts to demonstrate the existence of a mucoprotein abnormality in two
patients who showed the atypical peak were unsuccessful. These data do not
represent unequivocal evidence ruling out mucoprotein as a factor contributory
to the atypical peak.
Ultracentrifugation of the serum lipoprotein in familial amyloidosis has not
been previously reported. Review of the extensive literature as to the etiology
of systemic amyloidosis revealed no previous suggestion that lipoprotein dys-
metabolism might be involved in the process. Rather speculation has centered
about the possible role of immunological reactions, plasma cell dysfunction,
tissue ground substance changes, and macromolecular protein deposition. Despite
the fact that the methodologies of these experimental technics are inherently
different, it was believed that an investigation of lipoprotein function might
clarify the nebulous area of amyloid genesis and subclinical case identification.
When correlated with the abnormal findings of free electrophoresis, ultra-
centrifugal analysis of serum lipoproteins was found to represent an additional
experimental aid in diagnosis: twenty-seven of twenty-nine cases with the overt
or subclinical process demonstrated an abnormal elevation in one or more frac-
tion of these molecules. Furthermore, ultracentrifugal analysis was shown to be
of value in those cases wherein poorly resolved electrophoretic patterns were
obtained. In nine such cases serum lipoprotein elevations were found. Thus, not
only was the identification of the elusive subclinical subject further augmented,
but in eight cases was shown to have elevated lipoprotein components when
electrophoretic findings were interpreted as being negative. Thus it would seem
that the data obtained by these modalities is not only additive but is comple-
mentary as well.
A remarkable correlation was noted to exist between the results of these tech-
flies insofar as a more precise localization of the atypical area was concerned.
Ultracentrifugal analysis in 18 cases showed that the -S 25—40 and 20—25 frac-
tions, moving with a mobility similar to 3 and c12 globulin fractions respectively
were elevated. Thus, by means of these experimental methods, the residence of
the abnormal biochemical changes in the area described is more clearly defined.
While the subclinical individual has been identified by means of electrophoresis,
the degree of biochemical inheritance has been only partly ascertained due to
the limitations of the method. Ultracentrifugal analysis clearly demonstrated
varying degrees of lipoprotein gene inheritance in different family segments of
this pedigree. The most consistently transmissible elevated serum lipoprotein
fractions were those of the -S 25—40 and 20—25 group. Correlation of these find-
ings with sex or clinical disease appeared to be lacking.
Even though the data suggest that familial primary systemic amyloidosis
may represent at least in part a disturbance in lipoprotein metabolism, numerous
and as yet unknown factors may play a decisive role. The multitudinous proper-
ties and capacities of the blood vessel walls, the role of the ubiquitous connective
tissue ground substance, the responsiveness of internal and other tissues to
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amyloid deposition, and the little known intricacies of lipid metabolism and
related enzyme systems may all in some manner, singly or together, influence the
ultimate clinical course of the patient. Assuming these observations to be true,
one is impressed by the fact that the gene appears to be crucial in the funda-
mental processes that are involved.
SUMMARY
Sixty-six members of a large family pedigree have been investigated for the
presence or absence of clinical or subclinical inherited primary systemic amy-
loidosis by means of clinical, laboratory, and experimental biochemical methods.
In twenty-nine of these cases evidence for the existence of this disease process
has been obtained.
Based on these methods the inheritance of this disease has been shown to
assume the dominant form. The exhibition of free electrophoresis of the serum
and ultracentrifugation of serum lipoproteins has permitted effective identifica-
tion of subclinical patients. The importance of this finding in terms of genetic
data has been discussed.
The clinical findings in this pedigree, appearing with monotonous regularity
in the third and fourth decades, have been shown to consist of a bizarre constel-
lation: peripheral neuropathy, cardiovascular insufficiency, hepatic enlargement
and dysfunction, unusual ocular manifestations, gastrointestinal symptomatol-
ogy, and splenomegaly. The carpal tunnel syndrome has been described for the
first time in familial amyloidosis.
The non-specificity and inadequacy of the usual laboratory procedures in the
diagnosis of this process has been noted. Autopsy and the study of pathological
tissue confirming the diagnosis has been presented.
The demonstration in these patients by means of free electrophoresis of an
atypical peak migrating between the 3 and a globulin areas, and the demon-
stration of elevated serum lipoprotein by means of ultracentrifugation have
been emphasized. The use of these methods in the diagnosis of primary systemic
amyloidosis has been recommended.
The correlation between these experimental methods and the clinical expres-
sion of the disease has been described. The additive and correlative features of
these modalities has likewise been noted.
The demonstration by ultracentrifugation of abnormally elevated lipoproteins,
particularly in the -S 25—40 and 20—25 fractions, suggest that at least in part
familial primary systemic amyloidosis represents an inherited aberrancy in lipo-
protein metabolism.
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